Journal of Shanghai Jiao Tong University (Medical Science) ›› 2024, Vol. 44 ›› Issue (4): 462-468.doi: 10.3969/j.issn.1674-8115.2024.04.006
• Clinical research • Previous Articles Next Articles
HAO Mingxiu(
), CHEN Hongwei(), WANG Junlin, TANG Yinhan, WU Yunyun, JIN Yuhua, HU Yaomin()
Received:2023-09-25
Accepted:2024-03-04
Online:2024-04-28
Published:2024-04-28
Contact:
HU Yaomin
E-mail:haomingxiu@renji.com;chw13026736003@163.com;amin99@163.com
Supported by:CLC Number:
HAO Mingxiu, CHEN Hongwei, WANG Junlin, TANG Yinhan, WU Yunyun, JIN Yuhua, HU Yaomin. Investigation and epidemiological analysis of chronic diseases and comorbidities in hospitalized patients[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(4): 462-468.
Add to citation manager EndNote|Ris|BibTeX
URL: https://xuebao.shsmu.edu.cn/EN/10.3969/j.issn.1674-8115.2024.04.006
| Variable | Total (n=2 045) | Female (n=771) | Male (n=1 274) | P value |
|---|---|---|---|---|
| Age/year | 61.5±15.2 | 60.7±15.3 | 62.0±15.0 | 0.057 |
| Age range/n(%) | 0.173 | |||
| 30‒39 years | 114 (5.57) | 56 (7.26) | 58 (4.55) | |
| 40‒49 years | 362 (17.70) | 136 (17.64) | 226 (17.74) | |
| 50‒59 years | 568 (27.78) | 213 (27.63) | 355 (27.86) | |
| 60‒69 years | 370 (18.09) | 135 (17.51) | 235 (18.45) | |
| 70‒79 years | 332 (16.23) | 128 (16.60) | 204 (16.01) | |
| 80‒89 years | 209 (10.22) | 76 (9.86) | 133 (10.44) | |
| 90‒99 years | 90 (4.40) | 27 (3.50) | 63 (4.95) | |
| Hypertension/n(%) | 809 (43.68) | 235 (34.46) | 574 (49.06) | 0.000 |
| Diabetes mellitus/n(%) | 457 (24.81) | 113 (16.64) | 344 (29.58) | 0.000 |
| Hyperlipidemia/n(%) | 330 (18.38) | 107 (16.24) | 223 (19.63) | 0.074 |
| Coronary artery disease/n(%) | 213 (11.99) | 46 (7.01) | 167 (14.90) | 0.000 |
| Stroke/n(%) | 164 (9.29) | 41 (6.26) | 123 (11.08) | 0.000 |
| COPD/n(%) | 52 (2.96) | 4 (0.61) | 48 (4.35) | 0.000 |
| CKD/n(%) | 98 (5.56) | 24 (3.67) | 74 (6.67) | 0.008 |
| Malignant tumor/n(%) | 384 (21.48) | 140 (20.99) | 244 (21.77) | 0.704 |
| Thyroid nodule/n(%) | 452 (25.87) | 169 (26.45) | 283 (25.54) | 0.681 |
| Hyperthyroidism/n(%) | 20 (1.13) | 6 (0.92) | 14 (1.26) | 0.512 |
| Hypothyroidism/n(%) | 75 (4.24) | 43 (6.52) | 32 (2.89) | 0.000 |
| Rheumatic disease/n(%) | 35 (2.00) | 16 (2.45) | 19 (1.73) | 0.302 |
| Anxiety/depression/n(%) | 39 (2.22) | 13 (1.98) | 26 (2.36) | 0.673 |
Tab 1 Characteristics of the population and comparison between male and female patients
| Variable | Total (n=2 045) | Female (n=771) | Male (n=1 274) | P value |
|---|---|---|---|---|
| Age/year | 61.5±15.2 | 60.7±15.3 | 62.0±15.0 | 0.057 |
| Age range/n(%) | 0.173 | |||
| 30‒39 years | 114 (5.57) | 56 (7.26) | 58 (4.55) | |
| 40‒49 years | 362 (17.70) | 136 (17.64) | 226 (17.74) | |
| 50‒59 years | 568 (27.78) | 213 (27.63) | 355 (27.86) | |
| 60‒69 years | 370 (18.09) | 135 (17.51) | 235 (18.45) | |
| 70‒79 years | 332 (16.23) | 128 (16.60) | 204 (16.01) | |
| 80‒89 years | 209 (10.22) | 76 (9.86) | 133 (10.44) | |
| 90‒99 years | 90 (4.40) | 27 (3.50) | 63 (4.95) | |
| Hypertension/n(%) | 809 (43.68) | 235 (34.46) | 574 (49.06) | 0.000 |
| Diabetes mellitus/n(%) | 457 (24.81) | 113 (16.64) | 344 (29.58) | 0.000 |
| Hyperlipidemia/n(%) | 330 (18.38) | 107 (16.24) | 223 (19.63) | 0.074 |
| Coronary artery disease/n(%) | 213 (11.99) | 46 (7.01) | 167 (14.90) | 0.000 |
| Stroke/n(%) | 164 (9.29) | 41 (6.26) | 123 (11.08) | 0.000 |
| COPD/n(%) | 52 (2.96) | 4 (0.61) | 48 (4.35) | 0.000 |
| CKD/n(%) | 98 (5.56) | 24 (3.67) | 74 (6.67) | 0.008 |
| Malignant tumor/n(%) | 384 (21.48) | 140 (20.99) | 244 (21.77) | 0.704 |
| Thyroid nodule/n(%) | 452 (25.87) | 169 (26.45) | 283 (25.54) | 0.681 |
| Hyperthyroidism/n(%) | 20 (1.13) | 6 (0.92) | 14 (1.26) | 0.512 |
| Hypothyroidism/n(%) | 75 (4.24) | 43 (6.52) | 32 (2.89) | 0.000 |
| Rheumatic disease/n(%) | 35 (2.00) | 16 (2.45) | 19 (1.73) | 0.302 |
| Anxiety/depression/n(%) | 39 (2.22) | 13 (1.98) | 26 (2.36) | 0.673 |
Fig 1 Distributions of comorbidities of the study population
| Variable | Number of comorbidities | P value | ||||||
|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | 4 | 5 | ≥6 | ||
| Age/n(%) | 0.000 | |||||||
| 30‒39 years | 1 (12.5) | 12 (12.12) | 5 (5.10) | 19 (13.77) | 13 (7.56) | 19 (8.6) | 25 (2.26) | |
| 40‒49 years | 3 (37.5) | 14 (14.14) | 23 (23.47) | 35 (25.36) | 48 (27.91) | 57 (25.79) | 162 (14.63) | |
| 50‒59 years | 3 (37.5) | 38 (38.38) | 40 (40.82) | 43 (31.16) | 52 (30.23) | 62 (28.05) | 298 (26.92) | |
| 60‒69 years | 1 (12.5) | 15 (15.15) | 19 (19.39) | 20 (14.49) | 24 (13.95) | 38 (17.19) | 199 (17.98) | |
| 70‒79 years | 0 (0) | 16 (16.16) | 9 (9.18) | 19 (13.77) | 21 (12.21) | 15 (6.79) | 207 (18.70) | |
| 80‒89 years | 0 (0) | 2 (2.02) | 1 (1.02) | 2 (1.45) | 11 (6.40) | 29 (13.12) | 142 (12.83) | |
| 90‒99 years | 0 (0) | 2 (1.01) | 1 (1.02) | 0 (0) | 3 (1.74) | 1 (0.45) | 74 (6.68) | |
| Gender/n(%) | 0.043 | |||||||
| Female | 4 (50.0) | 44 (44.44) | 29 (29.59) | 45 (32.61) | 78 (45.35) | 87 (39.37) | 390 (35.23) | |
| Male | 4 (50.0) | 55 (55.56) | 69 (70.41) | 93 (67.39) | 94 (54.65) | 134 (60.63) | 717 (64.77) | |
Tab 2 Trends of comorbidities on different genders and age groups
| Variable | Number of comorbidities | P value | ||||||
|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | 4 | 5 | ≥6 | ||
| Age/n(%) | 0.000 | |||||||
| 30‒39 years | 1 (12.5) | 12 (12.12) | 5 (5.10) | 19 (13.77) | 13 (7.56) | 19 (8.6) | 25 (2.26) | |
| 40‒49 years | 3 (37.5) | 14 (14.14) | 23 (23.47) | 35 (25.36) | 48 (27.91) | 57 (25.79) | 162 (14.63) | |
| 50‒59 years | 3 (37.5) | 38 (38.38) | 40 (40.82) | 43 (31.16) | 52 (30.23) | 62 (28.05) | 298 (26.92) | |
| 60‒69 years | 1 (12.5) | 15 (15.15) | 19 (19.39) | 20 (14.49) | 24 (13.95) | 38 (17.19) | 199 (17.98) | |
| 70‒79 years | 0 (0) | 16 (16.16) | 9 (9.18) | 19 (13.77) | 21 (12.21) | 15 (6.79) | 207 (18.70) | |
| 80‒89 years | 0 (0) | 2 (2.02) | 1 (1.02) | 2 (1.45) | 11 (6.40) | 29 (13.12) | 142 (12.83) | |
| 90‒99 years | 0 (0) | 2 (1.01) | 1 (1.02) | 0 (0) | 3 (1.74) | 1 (0.45) | 74 (6.68) | |
| Gender/n(%) | 0.043 | |||||||
| Female | 4 (50.0) | 44 (44.44) | 29 (29.59) | 45 (32.61) | 78 (45.35) | 87 (39.37) | 390 (35.23) | |
| Male | 4 (50.0) | 55 (55.56) | 69 (70.41) | 93 (67.39) | 94 (54.65) | 134 (60.63) | 717 (64.77) | |
| Variable | Age group | P for trend | ||||||
|---|---|---|---|---|---|---|---|---|
| 30‒39 years | 40‒49 years | 50‒59 years | 60‒69 years | 70‒79 years | 80‒89 years | 90‒99 years | ||
| Hypertension/n(%) | 10 (11.49) | 77 (24.06) | 175 (34.25) | 158 (47.59) | 176 (57.14) | 148 (71.84) | 65 (73.86) | 0.000 |
| Diabetes mellitus/n(%) | 15 (15.63) | 37 (11.60) | 89 (17.62) | 95 (28.27) | 102 (33.89) | 87 (43.50) | 32 (37.65) | 0.000 |
| Hyperlipidemia/n(%) | 15 (16.30) | 71 (22.12) | 103 (20.52) | 56 (17.55) | 48 (16.61) | 27 (13.92) | 10 (12.82) | 0.010 |
| Coronary artery disease/n(%) | 0 (0) | 7 (2.28) | 34 (6.92) | 44 (13.88) | 39 (13.3) | 54 (27.14) | 35 (41.67) | 0.000 |
| Stroke/n(%) | 0 (0) | 2 (0.65) | 11 (2.25) | 19 (6.05) | 25 (8.68) | 65 (32.83) | 42 (50.0) | 0.000 |
| COPD/n(%) | 0 (0) | 0 (0) | 2 (0.41) | 5 (1.60) | 16 (5.59) | 13 (6.60) | 16 (19.51) | 0.000 |
| CKD/n(%) | 0 (0) | 3 (0.98) | 4 (0.82) | 6 (1.92) | 18 (6.25) | 37 (18.69) | 30 (35.71) | 0.000 |
| Malignant tumor/n(%) | 15 (17.24) | 30 (9.84) | 79 (15.86) | 72 (22.50) | 102 (34.69) | 63 (31.50) | 23 (27.38) | 0.000 |
| Rheumatic disease/n(%) | 1 (1.16) | 2 (0.66) | 5 (1.02) | 8 (2.56) | 12 (4.20) | 4 (2.12) | 3 (3.70) | 0.002 |
| Anxiety/depression/n(%) | 2 (2.30) | 1 (0.33) | 3 (0.61) | 8 (2.56) | 9 (3.11) | 9 (4.62) | 7 (8.33) | 0.000 |
Tab 3 Trend of prevalence of common chronic diseases with age
| Variable | Age group | P for trend | ||||||
|---|---|---|---|---|---|---|---|---|
| 30‒39 years | 40‒49 years | 50‒59 years | 60‒69 years | 70‒79 years | 80‒89 years | 90‒99 years | ||
| Hypertension/n(%) | 10 (11.49) | 77 (24.06) | 175 (34.25) | 158 (47.59) | 176 (57.14) | 148 (71.84) | 65 (73.86) | 0.000 |
| Diabetes mellitus/n(%) | 15 (15.63) | 37 (11.60) | 89 (17.62) | 95 (28.27) | 102 (33.89) | 87 (43.50) | 32 (37.65) | 0.000 |
| Hyperlipidemia/n(%) | 15 (16.30) | 71 (22.12) | 103 (20.52) | 56 (17.55) | 48 (16.61) | 27 (13.92) | 10 (12.82) | 0.010 |
| Coronary artery disease/n(%) | 0 (0) | 7 (2.28) | 34 (6.92) | 44 (13.88) | 39 (13.3) | 54 (27.14) | 35 (41.67) | 0.000 |
| Stroke/n(%) | 0 (0) | 2 (0.65) | 11 (2.25) | 19 (6.05) | 25 (8.68) | 65 (32.83) | 42 (50.0) | 0.000 |
| COPD/n(%) | 0 (0) | 0 (0) | 2 (0.41) | 5 (1.60) | 16 (5.59) | 13 (6.60) | 16 (19.51) | 0.000 |
| CKD/n(%) | 0 (0) | 3 (0.98) | 4 (0.82) | 6 (1.92) | 18 (6.25) | 37 (18.69) | 30 (35.71) | 0.000 |
| Malignant tumor/n(%) | 15 (17.24) | 30 (9.84) | 79 (15.86) | 72 (22.50) | 102 (34.69) | 63 (31.50) | 23 (27.38) | 0.000 |
| Rheumatic disease/n(%) | 1 (1.16) | 2 (0.66) | 5 (1.02) | 8 (2.56) | 12 (4.20) | 4 (2.12) | 3 (3.70) | 0.002 |
| Anxiety/depression/n(%) | 2 (2.30) | 1 (0.33) | 3 (0.61) | 8 (2.56) | 9 (3.11) | 9 (4.62) | 7 (8.33) | 0.000 |
| Variable | Diabetes mellitus | Hyperlipidemia | Coronary artery disease | Stroke | COPD | CKD | Malignant tumor | Rheumatic disease | Anxiety/ depression |
|---|---|---|---|---|---|---|---|---|---|
| Hypertension | 0.35① | 0.11① | 0.27① | 0.23① | 0.06① | 0.18① | 0.02 | 0.04 | 0.07① |
| Diabetes mellitus | 0.06① | 0.24① | 0.20① | 0.01 | 0.19① | 0.06① | 0.06① | -0.01 | |
| Hyperlipidemia | 0.11① | 0.10 | -0.02 | 0.08 | -0.06① | -0.02 | -0.01 | ||
| Coronary artery disease | 0.21① | 0.10① | 0.19① | 0.01 | 0.004 | 0.10① | |||
| Stroke | 0.13① | 0.29① | -0.004 | 0.03 | 0.15① | ||||
| COPD | 0.11① | 0.04 | 0.03 | 0.07① | |||||
| CKD | 0.04 | 0.04 | 0.05① | ||||||
| Malignant tumor | -0.02 | 0.05① | |||||||
| Rheumatic disease | 0.04 |
Tab 4 Correlation among common chronic diseases （r）
| Variable | Diabetes mellitus | Hyperlipidemia | Coronary artery disease | Stroke | COPD | CKD | Malignant tumor | Rheumatic disease | Anxiety/ depression |
|---|---|---|---|---|---|---|---|---|---|
| Hypertension | 0.35① | 0.11① | 0.27① | 0.23① | 0.06① | 0.18① | 0.02 | 0.04 | 0.07① |
| Diabetes mellitus | 0.06① | 0.24① | 0.20① | 0.01 | 0.19① | 0.06① | 0.06① | -0.01 | |
| Hyperlipidemia | 0.11① | 0.10 | -0.02 | 0.08 | -0.06① | -0.02 | -0.01 | ||
| Coronary artery disease | 0.21① | 0.10① | 0.19① | 0.01 | 0.004 | 0.10① | |||
| Stroke | 0.13① | 0.29① | -0.004 | 0.03 | 0.15① | ||||
| COPD | 0.11① | 0.04 | 0.03 | 0.07① | |||||
| CKD | 0.04 | 0.04 | 0.05① | ||||||
| Malignant tumor | -0.02 | 0.05① | |||||||
| Rheumatic disease | 0.04 |
| 1 | World Health Organization. The World Health Report 2008. Primary Health Cared Now more than ever[M].Geneva:World Health Organization, 2008: 148. |
| 2 | 曹丰, 王亚斌, 薛万国, 等. 中国老年疾病临床多中心报告[J]. 中华老年多器官疾病杂志, 2018, 17(11): 801-808. |
| CAO F, WANG Y B, XUE W G, et al. Clinical multi-centers report of chronic diseases among elderly inpatients in China[J]. Chinese Journal of Multiple Organ Diseases in the Elderly, 2018, 17(11): 801-808. | |
| 3 | 中国高血压防治指南修订委员会, 高血压联盟(中国)中华医学会心血管病学分会中国医师协会高血压专业委员会, 中国医疗保健国际交流促进会高血压分会, 等. 中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志, 2019, 24(1): 24-56. |
| Writing Group of 2018 Chinese Guidelines for the Management of Hypertension, Chinese Hypertension League, Chinese Society of Cardiology, Chinese Medical Doctor Association Hypertension Committee, Hypertension Branch of China International Exchange and Promotive Association for Medical and Health Care, et al. 2018 Chinese guidelines for the management of hypertension[J].Chinese Journal of Cardiovascular Medicine, 2019, 24(1): 24-56. | |
| 4 | 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J].中华糖尿病杂志, 2021, 13(4): 315-409. |
| Chinese Diabetes Society. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition)[J]. Chinese Journal of Diabetes, 2021, 13(4): 315-409. | |
| 5 | 中国成人血脂异常防治指南修订联合委员会.中国成人血脂异常防治指南(2016年修订版)[J]. 中华心血管病杂志, 2016, 44(10): 833-853. |
| Joint Committee Issued Chinese Guideline for the Management of Dyslipidemia. 2016 Chinese guideline for the management of dyslipidemia in adults[J]. Chinese Journal of Cardiovascular Disease, 2016, 44(10): 833-853. | |
| 6 | WILLADSEN T G, SIERSMA V, NICOLAISDÓTTIR D R, et al. Multimorbidity and mortality: a 15-year longitudinal registry-based nationwide Danish population study[J]. J Comorb, 2018, 8(1): 2235042X18804063. |
| 7 | MENOTTI A, MULDER I, NISSINEN A, et al. Prevalence of morbidity and multimorbidity in elderly male populations and their impact on 10-year all-cause mortality: the FINE study (Finland, Italy, Netherlands, Elderly)[J]. J Clin Epidemiol, 2001, 54(7): 680-686. |
| 8 | VOGELI C, SHIELDS A E, LEE T A, et al. Multiple chronic conditions: prevalence, health consequences, and implications for quality, care management, and costs[J]. J Gen Intern Med, 2007, 22(Suppl 3): 391-395. |
| 9 | ARAMRAT C, CHOKSOMNGAM Y, JIRAPORNCHAROEN W, et al. Advancing multimorbidity management in primary care: a narrative review[J]. Prim Health Care Res Dev, 2022, 23: e36. |
| 10 | SKOU S T, MAIR F S, FORTIN M, et al. Multimorbidity[J]. Nat Rev Dis Primers, 2022, 8: 48. |
| 11 | MCPARLAND C, COOPER M A, LOWE D J, et al. Multimorbidity, disease count, mortality and emergency care use in persons attending the emergency department: a cross-sectional data-linkage study[J]. J Multimorb Comorb, 2022, 12: 26335565221147417. |
| 12 | GARIN N, OLAYA B, PERALES J, et al. Multimorbidity patterns in a national representative sample of the Spanish adult population[J]. PLoS One, 2014, 9(1): e84794. |
| 13 | KIRCHBERGER I, MEISINGER C, HEIER M, et al. Patterns of multimorbidity in the aged population. Results from the KORA-Age study[J]. PLoS One, 2012, 7(1): e30556. |
| 14 | SINHA A, KERKETTA S, GHOSAL S, et al. Multimorbidity and complex multimorbidity in India: findings from the 2017-2018 longitudinal ageing study in India (LASI)[J]. Int J Environ Res Public Health, 2022, 19(15): 9091. |
| 15 | VAN DEN AKKER M, BUNTINX F, METSEMAKERS J F, et al. Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases[J]. J Clin Epidemiol, 1998, 51(5): 367-375. |
| 16 | PEFOYO A J, BRONSKILL S E, GRUNEIR A, et al. The increasing burden and complexity of multimorbidity[J]. BMC Public Health, 2015, 15: 415. |
| 17 | 中国老年保健医学研究会老年内分泌与代谢病分会, 中国毒理学会临床毒理专业委员会. 老年人多重用药安全管理专家共识[J]. 中国全科医学, 2018, 21(29): 3533-3544. |
| Endocrinology and Metabolism Branch of Chinese Association of Geriatric Research, Committee of Clinical Toxicology of Chinese Society of Toxicology. Expert consensus on risk management of polypharmacy in elderly[J]. Chinese General Practice, 2018, 21(29): 3533-3544. | |
| 18 | 黎艳娜, 王艺桥. 我国老年人慢性病共病现状及模式研究[J]. 中国全科医学, 2021, 24(31): 3955-3962, 3978. |
| LI Y N, WANG Y Q. Prevalence and patterns of multimorbidity among Chinese elderly people[J]. Chinese General Practice, 2021, 24(31): 3955-3962, 3978. | |
| 19 | 于普林, 王建业. 老年医学的现状和展望[J]. 中国实用内科杂志, 2011, 31(4): 244-246. |
| YU P L, WANG J Y. Current situation and prospect of geriatric medicine[J].Chinese Journal of Practical Medicine, 2011, 31(4): 244-246. | |
| 20 | 张新卉, 谷雨萌, 王仲言, 等. 三甲医院和社区医院老年慢性病共病现状调查[J]. 临床荟萃, 2021, 36(1): 39-43. |
| ZHANG X H, GU Y M, WANG Z Y, et al.Status investigation of chronic comorbidity status in elderly at tertiary hospitals and community hospitals[J]. Clinical Focus, 2021, 36(1): 39-43. | |
| 21 | 常晶, 侯原平, 吴金玲, 等. 住院老年共病患者5 505例疾病分布特点分析[J]. 中华老年多器官疾病杂志, 2014, 13(4): 251-254. |
| CHANG J, HOU Y P, WU J L, et al. Multi-morbidity patterns in Chinese elderly patients: an analysis of 5 505 in-hospital cases[J]. Chinese Journal of Multiple Organ Diseases in the Elderly, 2014,13(4): 251-254. | |
| 22 | 马珂, 冯玫, 赵瑞敏, 等. 全科医学科住院患者共病情况调查研究[J]. 中国全科医学, 2017, 20(23): 2820-2822. |
| MA K, FENG M, ZHAO R M, et al. Prevalence of comorbidity in inpatientes of department of general practice[J]. Chinese General Practice, 2017, 20(23): 2820-2822. | |
| 23 | ZHAO Y, ATUN R, OLDENBURG B, et al. Physical multimorbidity, health service use, and catastrophic health expenditure by socioeconomic groups in China: an analysis of population-based panel data[J]. Lancet Glob Health, 2020, 8(6): e840-e849. |
| 24 | WANG H H, WANG J J, WONG S Y, et al. Epidemiology of multimorbidity in China and implications for the healthcare system: cross-sectional survey among 162 464 community household residents in Southern China[J]. BMC Med, 2014, 12: 188. |
| 25 | RONG P, CHEN Y, DANG Y, et al. Geographical specific association between lifestyles and multimorbidity among adults in China[J]. PLoS One, 2023, 18(6): e0286401. |
| 26 | DENG X, DONG P, ZHANG L, et al. Health-related quality of life in residents aged 18 years and older with and without disease: findings from the First Provincial Health Services Survey of Hunan, China[J]. BMJ Open, 2017, 7(9): e015880. |
| 27 | GU J, CHAO J, CHEN W, et al. Multimorbidity and health-related quality of life among the community-dwelling elderly: a longitudinal study[J]. Arch Gerontol Geriatr, 2018, 74: 133-140. |
| [1] | WANG Jingyi, DENG Jiali, ZHU Yi, DING Xinyi, GUO Jiajing, WANG Zhongling. Experimental study on novel pH-responsive manganese-based nanoprobes for ferroptosis and magnetic resonance imaging in breast cancer [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(9): 1183-1193. |
| [2] | LI Siyu, CHEN Ya, HU Wentao, DAI Yongming, WU Yingwei. Using diffusion-relaxation correlation spectroscopic imaging to assess the heterogeneity of head and neck tumors and identify occult lymph node metastasis [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(9): 1202-1213. |
| [3] | WANG Rui, YUAN Ying, TAO Xiaofeng. Application value of synthetic magnetic resonance imaging in predicting cervical lymph node metastasis of oral cancer [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(7): 900-909. |
| [4] | SUN Lei, DAI Shifeng, CHEN Yuhua, XU Xinyi, JIANG Kele, LI Xiaowen, LI Chengjing, WU Tingting. Quantitative analysis of the distance between articular disc and condyle in patients with temporomandibular disorders [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(6): 684-692. |
| [5] | LI Zhuohang, YU Xindi, REN Jingya, SHEN Jia, DONG Suzhen, WANG Wei. Postoperative neurodevelopmental outcomes of end-to-side anastomosis for coarctation of the aorta [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(6): 753-759. |
| [6] | GU Liangrui, YAN Bicong, FANG Tonglei, WU Jinliang. Correlation between brain imaging features and cognitive impairment in end-stage renal disease patients based on susceptibility-weighted imaging [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(6): 760-765. |
| [7] | ZHANG Zhengjia, LI Xiaomin, ZHOU Xin, MA Hairong, AI Songtao. Preliminary study on the value of high-order functional magnetic resonance imaging in the evaluation of bone and soft tissue tumors [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(5): 585-596. |
| [8] | CAO Mingming, WANG Hui, YIN Yafu. Current research status of imaging markers for cognitive impairment in Parkinson′s disease [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(5): 646-652. |
| [9] | ZHANG Huihua, GAN Jing, HOU Miaomiao, LU Na. Bidirectional Mendelian randomization study of the relationship between brain imaging-derived phenotypes and obstructive sleep apnea [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(4): 468-475. |
| [10] | DENG Jiali, GUO Jiajing, WANG Jingyi, DING Xinyi, ZHU Yi, WANG Zhongling. Self -assembled drug -loaded nanoprobes for pyroptosis sensitization and chemical exchange saturation transfer imaging in breast cancer [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(3): 271-281. |
| [11] | SUN Yidan, YANG Xin. Functional MRI study on anxiety-enhanced temporomandibular joint pain [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(3): 342-348. |
| [12] | GAO Yuyan, LI Wei, WANG Shuting, KISHIMOTO Tomoko, ZHANG Ruyuan. Relationship between psychopathological symptoms and drug addiction, and mediating role of psychological distress in drug addicts [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(1): 51-59. |
| [13] | LI Chenxi, WANG Zirui, JIN Tianhao, ZHOU Zengtong, TANG Guoyao, SHI Linjun. Correlation between computer-assisted quantitative autofluorescence imaging results and the pathological grading of oral epithelial dysplasia in oral leukoplakia [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(9): 1146-1154. |
| [14] | LUO Rui, YANG Gongxin, SHI Huimin, HAN Yongshun, HE Yining, TIAN Zhen, WU Yingwei. Study of imaging characteristics of Kimura disease in the head and neck [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(9): 1182-1189. |
| [15] | LIU Yonghui, TANG Li, LIANG Taigang, ZHANG Jian, FENG Li. Research progress in the role of SIRT6 in aging and metabolism [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(11): 1439-1446. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
